In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

( NewsNation) — Losing muscle mass isn’t the only potential side effect of taking weight loss medications such as Ozempic: ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent.

Adults over 18 years of age are needed to participate in nutrition study to learn more about the effects of protein on body ...

A recent study suggests that people taking the GLP-1 liraglutide experienced more bone loss than people who exercised during ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Liraglutide lowered body mass, slowed weight gain and improved health markers in kids ages 6-11, according to research presented Sept. 10 at a medical conference and published in the New England ...

Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...

The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.